Asked by: Sarah Gibson (Liberal Democrat - Chippenham)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he has made an assessment of the potential merits of setting a national target to reduce the proportion of ultra-processed foods in the UK diet by 2030.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
UK dietary recommendations are based on robust independent risk assessments by the Scientific Advisory Committee on Nutrition (SACN). The SACN considered processed foods and health in 2023 and 2025. The SACN recommended that on balance, most people are likely to benefit from reducing their consumption of processed foods high in energy, saturated fat, salt, and free sugars, and which are low in fibre. Diets high in ultra-processed foods (UPF) are often energy dense, high in saturated fat, salt, or free sugars, high in processed meat and/or low in fruit, vegetables, and fibre. The SACN’s recommendations align with our existing policies for supporting healthier diets and our advice to consumers. Therefore, the Government does not currently have plans to introduce a national target to reduce the proportion of UPF in the diet of the United Kingdom’s population.
The Government is taking action to support people to make healthier choices. As set out in our 10-Year Health Plan, we will introduce mandatory healthy food sales reporting for all large companies in the food sector, and will set new targets to increase the healthiness of sales in all communities. This more strategic, outcomes-based approach aims to reduce less healthy food consumption, in line with UK dietary guidelines.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to raise awareness of sickle cell disease amongst the Latin American and Latinx community.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to improving the lives of those living with rare diseases such as sickle cell disease. Increasing awareness of rare diseases in healthcare professionals is one of the four priorities of the UK Rare Diseases Framework. We published the annual England action plan in February 2025, where we report on the steps we have taken to advance this priority.
In England, there are approximately 17,000 people living with sickle cell disease, an inherited blood disorder with approximately 250 new cases a year. It is the fastest growing genetic condition in the country. It is generally more common in people of black African and black Caribbean heritage, 77% of patients, however, we recognise that the condition is not unique to this community and NHS England remains committed to delivering quality improvement to all patients living with sickle cell.
Our national Can You Tell its Sickle Cell campaign launched in 2022, to boost public awareness of sickle cell disease, including in the Latin American and Latinx community, and help staff better understand the condition, crises, and how to care for patients during their greatest hour of need. Co-developed with NHS England’s patient advisory group, clinical experts, and the Sickle Cell Society, the campaign included staff resources as well as hand-held patient cards distributed via haemoglobinopathy coordinating centres. The campaign was relaunched as part of Sickle Cell Awareness Month in 2025, and an information toolkit remains available on the national Campaign Resource Centre.
Asked by: Alison Bennett (Liberal Democrat - Mid Sussex)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans his Department has to extend marketing restrictions for HFSS products to outdoor advertising.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Under the Health Mission, the Government is committed to prevention and to tackling obesity by creating a fairer, healthier food environment. We are already delivering the biggest public health reforms in a generation which includes restrictions on junk food advertising on television and online, a ban on high-caffeine energy drinks for children under 16 years old, and boosting the impact of the advertising and promotion restrictions by applying the updated Nutrient Profiling Model. We are also introducing mandatory healthy food sales reporting for large food businesses and will set new targets to increase the healthiness of sales in all communities, a world first.
Last year, the Government published the revised National Planning Policy Framework for local government, giving local authorities stronger, clearer powers to block new fast-food outlets near schools and where young people congregate. This will stop the relentless targeting of children and young people by the fast-food industry, which is a particular problem in some of the most deprived areas.
We welcome the work metropolitan mayors are progressing to support action being taken at a local level to ban junk food marketing across the public transport networks and public spaces that are controlled locally.
We currently have no plans to extend the marketing restrictions on products that are high in fat, sugar, and salt to outdoor advertising, but we continue to review the evidence of the impacts on children of advertising for less healthy food and drink products and will consider where further action is needed.
Asked by: Simon Opher (Labour - Stroud)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will increase funding for (a) the pathology (i) workforce, (ii) estates and (iii) IT infrastructure and (b) pathology disciplines involved in the pathways for cancer patients.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The 2025 Spending Review prioritised health, with record investment in the health and social care system. The Spending Review announced that annual National Health Service day-to-day spending will increase by £29 billion in real terms, a £53 billion cash increase, by 2028/29 compared to 2023/24.
To provide stability and ensure public services and industries have certainty in their funding, the Government has committed to holding a Spending Review every two years. The 2025 Spending Review sets departmental budgets for day-to-day spending up to 2028/29 and for capital for five years, to 2029/30. The envelope for the next Spending Review, due to be held in 2027, will be set in due course.
We will also publish a 10 Year Workforce Plan to ensure the NHS has the right people in the right places, with the right skills to deliver the best care for patients, when they need it.
As part of the £600 million in capital for diagnostics in 2025/26, announced as part of the Spending Review, the NHS is investing in histopathology automation technology, which will speed up pathology test reporting across England, helping to ensure that patients get their diagnoses faster and supporting reductions in elective waiting lists.
We are funding all pathology networks to increase digital capabilities by March 2026. This will reduce unnecessary waits and repeat tests to ensure that patients receive their blood test results sooner. These actions will help improve patient pathways, including for cancer.
Asked by: Bell Ribeiro-Addy (Labour - Clapham and Brixton Hill)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase diagnosis of sickle cell amongst patients of Latin American descent.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to improving the lives of those living with rare diseases such as sickle cell disease. Helping patients get a final diagnosis faster is one of the four priorities of the UK Rare Diseases Framework. We published the annual England action plan in February 2025, where we report on the steps we have taken to advance this priority.
In England, there are around 17,000 people living with sickle cell disease, an inherited blood disorder with around 250 new cases a year. It is the fastest growing genetic condition in the country. It is generally more common in people of Black African and Black Caribbean heritage (77% of patients) however, we recognise that the condition is not unique to this community and NHS England remain committed to delivering quality improvement to all patients living with sickle cell.
All pregnant women in England are offered a blood test to find out if they carry a gene for thalassaemia. Those at high risk of being a sickle cell carrier are offered a test for sickle cell. As part of the National Health Service Antenatal Sickle Cell and Thalassaemia (SCT) Screening Programme, the Family Origin Questionnaire (FOQ) is mandatory for all booking blood requests. By recording accurate family origin details, the FOQ enables midwives to identify women at higher risk. For example, women with Latin American ancestry extending back two generations are considered high risk and are offered screening accordingly.
Asked by: Helen Maguire (Liberal Democrat - Epsom and Ewell)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the adequacy of research funding allocated to pancreatic cancer given its rates of (a) mortality, (b) survival and (c) late diagnosis; and whether he plans to increase that funding.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department invests over £1.6 billion each year on research through its research delivery arm, the National Institute for Health and Care Research (NIHR), and in 2024/25, spent £141,649,374 on cancer research, signalling its high priority. This includes studies that focus specifically on pancreatic cancer as well as studies that are relevant or include pancreatic cancer. For example, between financial years 2020/21 and 2024/25, the NIHR committed £1.5 million to specific pancreatic cancer studies. The NIHR has also invested £1.9 million in research to detect early stages of gastrointestinal cancers, which includes pancreatic cancer. This non-invasive breath test will aim to streamline the referral process for primary care.
NIHR’s wider investments in research infrastructure, including facilities, services and the research workforce, supported the delivery of 160 pancreatic cancer research studies and enabled over 8,200 people to participate in potentially life-changing research during this time period. This includes support for the PemOla trial, which is the first to explore using precision immunotherapies to treat pancreatic cancer. More information about the trial is available at the following link:
https://cambridgebrc.nihr.ac.uk/2025/07/18/pancreatic-cancer-precision-medicine-trial/
Asked by: Simon Opher (Labour - Stroud)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will ensure that (a) universal lay terminology is used in the NHS app and (b) there is signposting to Lab Tests Online UK to enable patients to interpret their diagnostic results correctly.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The NHS App aims to use clear, universal lay terminology that is easy for the general public to understand. The content follows the National Health Service content style guide, which mandates writing in plain English to a reading age of nine to 11 years old. As part of the delivery of the 10-Year Health Plan, the NHS App will provide an improved and personalised experience for users, empowering them to access key elements of their health conditions like test results, and providing patients with advice and guidance 24 hours a day, seven days a week, that will help them to understand their health and make informed choices about what to do next.
We regularly test our content with patients to ensure it is clear and effective. This includes working with users who have access needs, low digital literacy, or are from seldom-heard groups.
This work builds on the current test results feature in the NHS App that is successfully used by millions of people each month to access the results of tests they have conducted with their general practitioner.
There is signposting to Lab Tests Online-UK (LTO-UK) to help patients interpret their diagnostic results, though this may depend on how the patient's general practice (GP) has configured its systems. We currently provide links to LTO-UK for approximately 70 of the most common test types. While the NHS App itself primarily displays results along with any accompanying doctor’s comments or actions, GP systems can have embedded links to LTO-UK alongside the test results, providing a direct route for patients to access reliable information at the point of care.
Asked by: Helen Morgan (Liberal Democrat - North Shropshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that NHS and care sector equipment is (a) returned and reused or (b) recycled after use.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
In October 2024 the Department published the Design for Life roadmap, a new strategy to transition away from all avoidable single-use medical technology (medtech) products towards a functioning circular system by 2045. This means designing, procuring, and processing medtech products and devices in a way that enables reuse, remanufacture, or recycling, thus preserving their value for as long as possible. The document sets out a plan of 30 actions to deliver the 2045 vision, which involve:
- driving positive behavioural change;
- exploring new commercial incentives to provide circular medtech;
- creating new standards to enable innovative products and services;
- planning the decontamination and recycling infrastructure of the future; and
- establishing new collaborations to accelerate the emergence of transformative science.
The Design for Life Roadmap is available at the following link:
https://assets.publishing.service.gov.uk/media/679ca015a9ee53687470a2ed/design-for-life-roadmap.pdf
Asked by: Matt Vickers (Conservative - Stockton West)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make an estimate of the number of practicing clinicians who have received specialist training in (a) diagnosing and (b) treating Avoidant/Restrictive Food Intake Disorder.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
In 2021, NHS England commissioned training for staff delivering treatment in inpatient children and young people’s mental health services to improve the understanding and management of Avoidant/Restrictive Food Intake Disorder (ARFID).
NHS England does not hold centralised data on the number of clinicians who have received specialist ARFID training. Training is commissioned and delivered locally to meet the needs of local populations.
Asked by: Danny Chambers (Liberal Democrat - Winchester)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will host the Global Ministerial Meeting on Antimicrobial Resistance in 2028.
Answered by Zubir Ahmed - Parliamentary Under-Secretary (Department of Health and Social Care)
The United Kingdom is looking forward to participating actively in the fifth Ministerial High-Level Conference on antimicrobial resistance (AMR) which will be held in Nigeria in 2026. The Government is considering how best to celebrate the 2028 centenary of the UK's discovery of penicillin. We will internally consider whether this will include bidding to host the sixth Ministerial High-Level Conference on AMR, which will take place in 2028.